LuanP. V.; TienN. D.; HaiN. M.; TienN. D.; DuyenT. T. Real-World Analysis of the Effect of Gefitinib As a First-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer With EGFR Mutations. YDLS 2021, 15.